Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Thoracic Surgery

Free Subscription Articles published in Eur Heart J Retrieve available abstracts of 101 articles: HTML format

Single Articles

April 2025
1. ZITO F, Rhellab R, de Keijzer AR
   Patient-prosthesis mismatch after aortic valve replacement: one size does not fit all.
   Eur Heart J. 2025 Apr 10:ehaf200. doi: 10.1093.
   PubMed    
   
   
   
2. BAY B, Tanner R, Gao M, Oliva A, et al
   Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary interventiondagger.
   Eur Heart J. 2025 Apr 10:ehaf196. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. TCHETCHE D, Pibarot P, Bax JJ, Bonaros N, et al
   Transcatheter vs. surgical aortic valve replacement in women: the RHEIA trial.
   Eur Heart J. 2025 Apr 2:ehaf133. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2025
4. BUSCHER A, Plagwitz L, Yildirim K, Brix TJ, et al
   Deep Learning Electrocardiogram Model for Risk Stratification of Coronary Revascularization Need in the Emergency Department.
   Eur Heart J. 2025 Mar 29:ehaf254. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. COLLI A, Besola L, De Caterina R
   Routine left atrial appendage surgical closure for all patients undergoing cardiac surgery?
   Eur Heart J. 2025 Mar 25:ehaf122. doi: 10.1093.
   PubMed    
   
   
   
6. BYRNE RA, Valgimigli M, Bhatt DL, Coughlan JJ, et al
   Great debate: default duration of dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndrome should be 12 months.
   Eur Heart J. 2025 Mar 8:ehaf070. doi: 10.1093.
   PubMed    
   
   
   
7. CALAFIORE AM, Prapas S, Gaudino M
   Arterial conduits for coronary bypass grafting: the set-point concept.
   Eur Heart J. 2025;46:922-925.
   PubMed     Abstract available
   
   
   
8. BROWN SD, Rodor J, Baker AH
   Targeted approach for next-generation coronary stents.
   Eur Heart J. 2025 Mar 3:ehaf007. doi: 10.1093.
   PubMed    
   
   
   February 2025
9. THELIN S, Modrau IS, Duvernoy O, Dalen M, et al
   No-touch vein grafts in coronary artery bypass surgery: a registry-based randomized clinical trial.
   Eur Heart J. 2025 Feb 19:ehaf018. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. SPRINGHETTI P, Abdoun K, Dumont E, Dagenais F, et al
    Sex-related differences in prosthesis-patient mismatch after surgical aortic valve replacement and long-term outcomes.
    Eur Heart J. 2025 Feb 18:ehaf076. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. DE PAULIS R, Chirichilli I, de Kerchove L, Della Corte A, et al
    Current status of aortic valve repair surgery.
    Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. ABDELHAMID M, Abdel Meged AM, Prendergast B, Calvo-Iglesias FE, et al
    Baseline characteristics and outcomes of rheumatic mitral valve disease: the EURObservational Research Programme Valvular Heart Disease II Survey.
    Eur Heart J. 2025 Feb 11:ehaf050. doi: 10.1093.
    PubMed     Abstract available
    
    
    
13. ROMAN M, Miksza J, Lai FY, Sze S, et al
    Revascularization in frail patients with acute coronary syndromes: a retrospective longitudinal study.
    Eur Heart J. 2025;46:535-547.
    PubMed     Abstract available
    
    
    
14. RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al
    Microvascular resistance reserve: impact on health status and myocardial perfusion after revascularization in chronic coronary syndrome.
    Eur Heart J. 2025;46:424-435.
    PubMed     Abstract available
    
    
    January 2025
15. MATSUMOTO S, Ohno Y, Noda S, Miyamoto J, et al
    Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
    Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093.
    PubMed     Abstract available
    
    
    
16. HOJSGAARD JORGENSEN T, Horsted Thyregod HG, De Backer O
    Coronary revascularization in the NOTION-2 trial: an in-depth data analysis.
    Eur Heart J. 2025 Jan 9:ehae763. doi: 10.1093.
    PubMed    
    
    
    
17. AARTS HM, Voskuil M, Delewi R
    Coronary revascularization in randomized clinical trials comparing transcatheter and surgical aortic valve replacement: is it time to bridge the gap?
    Eur Heart J. 2025 Jan 9:ehae762. doi: 10.1093.
    PubMed    
    
    
    
18. ZHAO Y, Sun J, Lv X
    What truly drives the significant reduction in major adverse cardiac events after switching to electronic cigarettes following percutaneous coronary intervention?
    Eur Heart J. 2025 Jan 8:ehae895. doi: 10.1093.
    PubMed    
    
    
    
19. WILKINSON C, Bhatty A, Batra G, Aktaa S, et al
    Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
    Eur Heart J. 2025;46:190-214.
    PubMed     Abstract available
    
    
    
20. CREA F
    Challenges with oral anticoagulants: bridging before surgery and concomitant use of non-steroidal anti-inflammatory drugs. Focus on revascularization of ischaemic cardiomyopathy and e-cigarettes after percutaneous coronary intervention.
    Eur Heart J. 2025;46:1-5.
    PubMed    
    
    
    December 2024
21. OKADA T, Kurihara O, Takano M
    Takotsubo syndrome during percutaneous coronary intervention: the role of myocardial ischaemia and microvascular dysfunction in pathophysiology.
    Eur Heart J. 2024 Dec 24:ehae902. doi: 10.1093.
    PubMed    
    
    
    
22. ROFFI M, Montalescot G
    Oral P2Y12 inhibitor pre-treatment for percutaneous coronary intervention in non-ST-elevation acute coronary syndromes: evolving notions in ESC guidelines.
    Eur Heart J. 2024 Dec 4:ehae616. doi: 10.1093.
    PubMed    
    
    
    November 2024
23. OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al
    Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry.
    Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. VERGALLO R, Patrono C
    STOPDAPT-3 one-year results support similar efficacy and safety of aspirin and clopidogrel after percutaneous coronary intervention.
    Eur Heart J. 2024 Nov 19:ehae773. doi: 10.1093.
    PubMed    
    
    
    
25. LI Z, Xiang D, Hu K
    Thoracoscopic hypothermic fibrillatory arrest mitral valve replacement for severe mitral regurgitation in Marfan syndrome after Bentall procedure.
    Eur Heart J. 2024 Nov 12:ehae772. doi: 10.1093.
    PubMed    
    
    
    
26. MUNZEL T, Daiber A, Prochaska J
    How quitting, switching to e-cigarettes, or sticking to smoking shapes cardiovascular outcomes after percutaneous coronary intervention.
    Eur Heart J. 2024 Nov 11:ehae756. doi: 10.1093.
    PubMed    
    
    
    October 2024
27. BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al
    Coronary artery bypass grafting vs. percutaneous coronary intervention in severe ischaemic cardiomyopathy: long-term survival.
    Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. RHEUDE T, Ruge H, Altaner N, Pellegrini C, et al
    Comparison of strategies for vascular ACCESS closure after transcatheter aortic valve implantation: the ACCESS-TAVI randomized trial.
    Eur Heart J. 2024 Oct 29:ehae784. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. KANG D, Choi KH, Kim H, Park H, et al
    Prognosis after switching to electronic cigarettes following percutaneous coronary intervention: a Korean nationwide study.
    Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. SANDNER S, Antoniades C, Caliskan E, Czerny M, et al
    Intra-operative and post-operative management of conduits for coronary artery bypass grafting: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Surgery and the European Association for Cardio-Thoraci
    Eur Heart J. 2024 Oct 16:ehae654. doi: 10.1093.
    PubMed     Abstract available
    
    
    
31. 
    Correction to: Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093.
    PubMed    
    
    
    September 2024
32. GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al
    Great debate: myocardial infarction after cardiac surgery must be redefined.
    Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093.
    PubMed    
    
    
    
33. SCHOFER N, Blankenberg S
    Transfemoral or surgical aortic valve replacement in young low-risk patients with tricuspid and bicuspid aortic valve stenosis.
    Eur Heart J. 2024 Sep 5:ehae537. doi: 10.1093.
    PubMed    
    
    
    
34. SATO M, Yoshijima N, Yashima F
    Sinus sequestration due to transcatheter heart valve endothelialization after transcatheter aortic valve replacement.
    Eur Heart J. 2024 Sep 4:ehae606. doi: 10.1093.
    PubMed    
    
    
    
35. PRENDERGAST BD, Patterson T, Redwood S
    Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful prevention.
    Eur Heart J. 2024;45:3042-3044.
    PubMed    
    
    
    
36. ACKERMANN P, Abdel-Wahab M, Noack T
    Macroscopic findings of severe structural valve deterioration of a transcatheter aortic bioprosthesis.
    Eur Heart J. 2024;45:3092.
    PubMed    
    
    
    
37. MARTINSSON A, Jeppsson A
    Invited editorial on "Outcome of aortic valve replacement versus conservative treatment in asymptomatic patients with severe aortic stenosis - Five years follow-up of the AVATAR randomized controlled trial" by Banovic et al.
    Eur Heart J. 2024 Sep 1:ehae597. doi: 10.1093.
    PubMed    
    
    
    
38. BANOVIC M, Putnik S, Da Costa BR, Penicka M, et al
    Aortic valve replacement versus conservative treatment in asymptomatic severe aortic stenosis: long-term follow-up of the AVATAR trial.
    Eur Heart J. 2024 Sep 1:ehae585. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
39. WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al
    Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention: 1-Year Follow-up of the STOPDAPT-3 Trial.
    Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
40. DREYFUS J, Juarez-Casso F, Sala A, Carnero-Alcazar M, et al
    Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE.
    Eur Heart J. 2024 Aug 30:ehae578. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. VALGIMIGLI M, Landi A
    Bleeding risk should guide antithrombotic treatment after percutaneous coronary intervention: a Copernican revolution.
    Eur Heart J. 2024 Aug 28:ehae542. doi: 10.1093.
    PubMed    
    
    
    
42. PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al
    Coronary artery disease management in older adults: revascularization and exercise training.
    Eur Heart J. 2024;45:2811-2823.
    PubMed     Abstract available
    
    
    
43. SCHELLER B, Zeller T
    Paclitaxel-coated balloons: the more you gain the more you get.
    Eur Heart J. 2024;45:2848-2850.
    PubMed    
    
    
    
44. BAI L, Feng Y, Chen M
    A very rare complication of transcatheter aortic valve replacement.
    Eur Heart J. 2024 Aug 14:ehae316. doi: 10.1093.
    PubMed    
    
    
    
45. PEDICINO D, Vergallo R
    Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis - the AGENT IDE trial.
    Eur Heart J. 2024;45:2592-2593.
    PubMed    
    
    
    July 2024
46. BESOLA L, Colli A, De Caterina R
    Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?
    Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. KANG J, Yun J, Park KW, Park M, et al
    Long-term outcomes of high bleeding risk patients undergoing percutaneous coronary intervention: a Korean nationwide registry.
    Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. CREA F
    Focus on acute myocardial infarction, sex-related differences in coronary bypass surgery, inflammation in heart failure, and infective endocarditis in prosthetic valves.
    Eur Heart J. 2024;45:2463-2467.
    PubMed    
    
    
    
49. CAFORIO ALP, Kaski JP, Gimeno JR, Elliott PM, et al
    Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry.
    Eur Heart J. 2024;45:2548-2569.
    PubMed     Abstract available
    
    
    
50. ANDREOTTI F, De Caterina R
    Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed.
    Eur Heart J. 2024 Jul 16:ehae402. doi: 10.1093.
    PubMed    
    
    
    
51. WANG J, Hu P, Ma XJ
    Mechanical mitral valve obstruction: gone with the wind.
    Eur Heart J. 2024 Jul 16:ehae431. doi: 10.1093.
    PubMed    
    
    
    
52. GARCIA-VILLARREAL OA, Anselmi A, Beurtheret S
    Time is relative, also when comparing transcatheter edge-to-edge repair to mitral valve surgery.
    Eur Heart J. 2024 Jul 10:ehae383. doi: 10.1093.
    PubMed    
    
    
    
53. BERNARD A, Deharo P, Fauchier L
    Time matters when considering treatment for patients with mitral regurgitation.
    Eur Heart J. 2024 Jul 10:ehae384. doi: 10.1093.
    PubMed    
    
    
    
54. DIMITRIADIS K, Pyrpyris N, Tsioufis K
    Long-term outcomes of transcatheter vs. surgical aortic valve replacement: is there still a question to be answered?
    Eur Heart J. 2024 Jul 2:ehae386. doi: 10.1093.
    PubMed    
    
    
    
55. THYREGOD HGH, De Backer O, Sondergaard L
    A notion of bioprosthetic aortic valve durability.
    Eur Heart J. 2024 Jul 2:ehae387. doi: 10.1093.
    PubMed    
    
    
    June 2024
56. HOLFELD J, Nagele F, Polzl L, Engler C, et al
    Cardiac shockwave therapy in addition to coronary bypass surgery improves myocardial function in ischaemic heart failure: the CAST-HF trial.
    Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al
    Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis.
    Eur Heart J. 2024;45:2052-2062.
    PubMed     Abstract available
    
    
    
58. ZHUANG Y, Wang W, Lu F
    Simultaneous transcatheter aortic and tricuspid valve replacement via bilateral cervical approach.
    Eur Heart J. 2024 Jun 12:ehae352. doi: 10.1093.
    PubMed    
    
    
    
59. DOENST T, Faerber G
    Challenge-skill balance in cardiac surgery: an attempt to explain sex-related differences in coronary surgery.
    Eur Heart J. 2024 Jun 11:ehae350. doi: 10.1093.
    PubMed    
    
    
    
60. BEERKENS FJ, Bhatt DL
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
    Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093.
    PubMed    
    
    
    
61. CREA F
    Optimizing the treatment of severe aortic stenosis.
    Eur Heart J. 2024;45:1861-1865.
    PubMed    
    
    
    
62. VERGALLO R, Pedicino D
    Weekly Journal Scan: transcatheter aortic valve implantation in patients with small aortic annulus.
    Eur Heart J. 2024 Jun 1:ehae308. doi: 10.1093.
    PubMed    
    
    
    May 2024
63. REN J, Bowyer A, Tian DH, Royse C, et al
    Multiple arterial vs. single arterial coronary artery bypass grafting: sex-related differences in outcomes.
    Eur Heart J. 2024 May 31:ehae294. doi: 10.1093.
    PubMed     Abstract available
    
    
    
64. MARIN-CUARTAS M, Tang GHL, Kiefer P, Fukuhara S, et al
    Transcatheter heart valve explant with infective endocarditis-associated prosthesis failure and outcomes: the EXPLANT-TAVR international registry.
    Eur Heart J. 2024 May 31:ehae292. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. VAN DE KAR MRD, van Brakel TJ, Van't Veer M, van Steenbergen GJ, et al
    Anticoagulation for post-operative atrial fibrillation after isolated coronary artery bypass grafting: a meta-analysis.
    Eur Heart J. 2024 May 29:ehae267. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al
    Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management.
    Eur Heart J. 2024 May 28:ehae245. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. KWON O, Ahn JH, Koh JS, Park Y, et al
    Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular events after percutaneous coronary interventions.
    Eur Heart J. 2024 May 28:ehae296. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. HARIK L, Gaudino M
    Coronary angiography and bypass surgery: born together and now going separate ways?
    Eur Heart J. 2024;45:1816-1818.
    PubMed    
    
    
    
69. SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al
    Coronary bypass surgery guided by computed tomography in a low-risk population.
    Eur Heart J. 2024;45:1804-1815.
    PubMed     Abstract available
    
    
    
70. ROFFI M, Meier B, Gallino A
    Fifty years of percutaneous transluminal angioplasty.
    Eur Heart J. 2024;45:1779-1780.
    PubMed    
    
    
    
71. DVIR D, Tchetche D, Leon MB, Genereux P, et al
    Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.
    Eur Heart J. 2024 May 15:ehae303. doi: 10.1093.
    PubMed     Abstract available
    
    
    
72. JORGENSEN TH, Thyregod HGH, Savontaus M, Willemen Y, et al
    Transcatheter Aortic Valve Implantation in Low-Risk Tricuspid or Bicuspid Aortic Stenosis: The NOTION-2 Trial.
    Eur Heart J. 2024 May 15:ehae331. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al
    Periprocedural myocardial infarction after percutaneous coronary intervention and long-term mortality: a meta-analysis.
    Eur Heart J. 2024 May 14:ehae266. doi: 10.1093.
    PubMed     Abstract available
    
    
    
74. VERGALLO R, Patrono C
    Weekly journal scan: intravascular imaging to guide percutaneous coronary intervention-ready for prime time?
    Eur Heart J. 2024 May 4:ehae242. doi: 10.1093.
    PubMed    
    
    
    April 2024
75. PIBAROT P
    Transcatheter aortic valve replacement: benchmarking practices to optimize quality and outcomes.
    Eur Heart J. 2024 Apr 26:ehae174. doi: 10.1093.
    PubMed    
    
    
    
76. KIM YY, Lluri G, Haeffele C, Daugherty T, et al
    Hepatocellular carcinoma in survivors after Fontan operation: a case-control study.
    Eur Heart J. 2024;45:1477-1480.
    PubMed    
    
    
    
77. VERGALLO R, Galiuto L
    Weekly journal scan: angina severity reduced by percutaneous coronary intervention in the ORBITA-2 trial.
    Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093.
    PubMed    
    
    
    
78. BLEIZIFFER S
    Transcatheter vs. surgical treatment of aortc stenosis: long awaited long-term data, yet a long way to go.
    Eur Heart J. 2024;45:1125-1126.
    PubMed    
    
    
    
79. WINDECKER S, Gilard M, Achenbach S, Cribier A, et al
    Device innovation in cardiovascular medicine: a report from the European Society of Cardiology Cardiovascular Round Table.
    Eur Heart J. 2024;45:1104-1115.
    PubMed     Abstract available
    
    
    
80. WAYDA B
    Machine perfusion of marginal donor hearts: a valuable tool, but where and for whom?
    Eur Heart J. 2024;45:1178.
    PubMed    
    
    
    
81. AMESZ JH, Taverne YJHJ, Manintveld OC
    To transplant or not to transplant 'marginal' donor hearts: is machine perfusion the answer?
    Eur Heart J. 2024;45:1177.
    PubMed    
    
    
    March 2024
82. FRANK D, Durand E, Lauck S, Muir DF, et al
    A streamlined pathway for transcatheter aortic valve implantation: the BENCHMARK study.
    Eur Heart J. 2024 Mar 30:ehae147. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. BAKAR SN, Ong G, Fam NP
    LuX-Valve Plus transcatheter tricuspid valve replacement for massive tricuspid flail after lead extraction.
    Eur Heart J. 2024 Mar 29:ehae165. doi: 10.1093.
    PubMed    
    
    
    
84. 
    Correction to: Healthcare resource utilisation and safety outcomes in patients undergoing transcatheter mitral valve repair - A nationwide analysis.
    Eur Heart J. 2024 Mar 25:ehae168. doi: 10.1093.
    PubMed    
    
    
    
85. BAX JJ, Hahn RT, Marsan NA, Baumgartner H, et al
    Great debate: symptomatic moderate aortic stenosis should undergo intervention.
    Eur Heart J. 2024 Mar 6:ehae050. doi: 10.1093.
    PubMed    
    
    
    
86. MARTINSSON A, Rasalingam R, Jeppsson A
    Stable incidence and outcomes for patients with incident aortic stenosis: how can we translate excellent trial data into improved clinical outcomes in the population?
    Eur Heart J. 2024 Mar 6:ehae078. doi: 10.1093.
    PubMed    
    
    
    
87. URSO S, Sadaba R, Dayan V
    Benefits of coronary artery bypass grafting over percutaneous coronary intervention in left main disease: the strength of the evidence.
    Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093.
    PubMed    
    
    
    
88. SUDO K, Nakamura K, Sato A
    Usefulness of endomyocardial biopsy using three-dimensional delivery system for the diagnosis of cardiac amyloidosis with complete atrioventricular block after transcatheter aortic valve implantation.
    Eur Heart J. 2024 Mar 5:ehae137. doi: 10.1093.
    PubMed    
    
    
    
89. MEHILLI J
    Shortening in-hospital stay after transcatheter aortic valve implantation: a deja vu in percutaneous interventions.
    Eur Heart J. 2024 Mar 4:ehae096. doi: 10.1093.
    PubMed    
    
    
    
90. DURAND E, Beziau-Gasnier D, Michel M, Iung B, et al
    Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
    Eur Heart J. 2024 Mar 4:ehae081. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. MAISANO F, Hahn R, Sorajja P, Praz F, et al
    Transcatheter treatment of the tricuspid valve: current status and perspectives.
    Eur Heart J. 2024 Mar 1:ehae082. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2024
92. LURZ P, Kresoja KP
    Surgical or percutaneous treatment of mitral regurgitation: clip or cut?
    Eur Heart J. 2024 Feb 21:ehae084. doi: 10.1093.
    PubMed    
    
    
    
93. NISHIHIRA K, Asano Y, Shibata Y
    Efficacy of paclitaxel-coated balloon angioplasty combined with intensive lipid-lowering therapy for ST-segment elevation myocardial infarction: insights from near-infrared spectroscopy.
    Eur Heart J. 2024 Feb 15:ehae073. doi: 10.1093.
    PubMed    
    
    
    
94. THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al
    Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial.
    Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
95. DEHARO P, Obadia JF, Guerin P, Cuisset T, et al
    Mitral transcatheter edge to edge repair versus isolated mitral surgery for severe mitral regurgitation: A French nationwide study.
    Eur Heart J. 2024 Jan 19:ehae046. doi: 10.1093.
    PubMed     Abstract available
    
    
    
96. HAUSLEITER J, Lachmann M, Stolz L, Bedogni F, et al
    Artificial intelligence-derived risk score for mortality in secondary mitral regurgitation treated by transcatheter edge-to-edge repair: the EuroSMR risk score.
    Eur Heart J. 2024 Jan 19:ehad871. doi: 10.1093.
    PubMed     Abstract available
    
    
    
97. VERGALLO R, Galiuto L
    Targeting inflammation with colchicine does not prevent atrial fibrillation after major non-cardiac thoracic surgery.
    Eur Heart J. 2024 Jan 18:ehae006. doi: 10.1093.
    PubMed    
    
    
    
98. BENFARI G, Essayagh B, Michelena HI, Ye Z, et al
    Severe aortic stenosis: secular trends of incidence and outcomes.
    Eur Heart J. 2024 Jan 8:ehad887. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
99. LI XM, Zhu XJ, Jing ZC
    Reverse cardiac remodelling after balloon atrial septostomy for pulmonary arterial hypertension and end-stage heart failure.
    Eur Heart J. 2023 Dec 16:ehad822. doi: 10.1093.
    PubMed    
    
    
    November 2023
100. LU ZN, Yang Y, Song G
     A patient-tailored clipping strategy of transcatheter edge-to-edge repair as salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet flails.
     Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093.
     PubMed    
     
     
     September 2023
101. BEYGUI F, Guillemot V, Saloux E
     Complex mitral para-prosthetic leak closure as a bridge to heart transplant.
     Eur Heart J. 2023 Sep 28:ehad602. doi: 10.1093.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Thoracic Surgery is free of charge.